div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 6button div class=ts-image amp-img class=ts-thumb alt=Page 6: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails6jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 7button div class=ts-image amp-img class=ts-thumb alt=Page 7: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails7jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 8button div class=ts-image amp-img class=ts-thumb alt=Page 8: repebisupcheduperepebisupchedupearticulosactamedperv31n3a4pdfen pacientes con OA de rodilla divididos en dos grupos durante tres meses de tratamiento diario via oral src=https:reader034vdocumentscoreader034viewer20220422005ea0a35e03cc450e060d9fa9html5thumbnails8jpg width=142 height=106 layout=responsive amp-img divdiv